BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

3:49 PM
 | 
Apr 03, 2018
 |  BC Extra  |  Company News

Management tracks: Abeona, Dermavant, Assembly

Gene therapy play Abeona Therapeutics Inc. (NASDAQ:ABEO) said President and CEO Timothy Miller will transition to president and CSO. He is succeeded as CEO by Carsten Thiel, who was EVP and chief commercial officer at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN).

The Dermavant Sciences dermatology subsidiary of Roivant Sciences GmbH (Basel, Switzerland) hired David Rubenstein as CSO, Richard Peterson as CFO, Ariel Jasie as chief business and strategy officer and Chris Van Tuyl as general counsel. Rubenstein...

Read the full 351 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >